EBR stumbles after FDA issues news delay warning

SYDNEY: Cardiac disease specialist, EBR Systems (ASX:EBR), tumbled 11% this morning after providing a status

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In